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A Human Health Risk Assessment (HHRA) was undertaken for a proposed park development “River 
Landing”, to be constructed along the north bank of the South Saskatchewan River in the City of Saskatoon, 
Saskatchewan, Canada. The purpose of the HHRA was to determine whether chemical constituents 
identified at the site, including polycyclic aromatic hydrocarbons (PAHs), petroleum hydrocarbons (PHCs), 
and toxic and heavy metals, would adversely affect the health of construction workers and potential park 
users. Although more traditional remediation options were considered, the risk assessment approach was 
chosen since it represented the best available technology. The HHRA was undertaken using protocols and 
methodologies proposed and readily accepted by the Canadian Council of Ministers of the Environment 
(CCME), Health Canada, and the United States Environmental Protection Agency (US EPA). Results of 
the risk assessment revealed that the magnitude and distribution of the chemicals at the site were such 
that extensive remediation was not required, and that the site could be developed without any significant 
restrictions on the proposed use. The assessment revealed that potential exposure to soil constituents 
would not result in adverse health risk to construction workers involved in park development or future 
park users.
KEY WORDS: chemical contaminants, environmental site assessment, heavy metals, petroleum, 
polycyclic aromatic hydrocarbons, river landing, soil, toxic metals
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The city of Saskatoon is located in central 
Saskatchewan on the South Saskatchewan River, 
and is the most populous city in the province with a 
population of approximately two hundred and thirty 
thousand (1). Saskatoon is often referred to as the 
“City of Bridges” for its seven river crossings that 
connect the east and west areas of the city. The city is 
engaged in the redevelopment of its south downtown. 
This redevelopment will result in a revitalization of the 
City’s south downtown with the development of a 
hotel, a spa, and a park along the South Saskatchewan 
River.
A Human Health Risk Assessment (HHRA) was 
undertaken for a proposed park development “River 
Landing” to be constructed along the north bank of the 
South Saskatchewan River. The purpose of the HHRA 
was to determine whether chemical constituents 
identified at the site, including polycyclic aromatic 
hydrocarbons (PAHs), petroleum hydrocarbons 
(PHCs), and toxic and heavy metals, would adversely 
affect the health of construction workers and future 
park users.
Toxic and heavy metals, such as arsenic, 
cadmium, lead, copper, nickel, and mercury, are 
important environmental contaminants and raise 
concern for human health because of their presence 
in environmental media and the potential for 
occupational, residential, and recreational exposure 
(2). Heavy metal toxicity can result in damaged or 
reduced central nervous system, hematological, 
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respiratory, cardiovascular, kidney, and liver function (3-
6). Long-term exposure to heavy metals is associated 
with degenerative processes that mimic Alzheimer’s 
disease, Parkinson’s disease, muscular dystrophy, and 
multiple sclerosis (7, 8). Repeated long-term contact 
with some metals or their compounds may cause 
allergies and even cancer (9-11). Exposure to some 
heavy metals at levels slightly above those naturally 
occurring in the environment can result in adverse 
health effects in humans (12-14).
PAHs are natural products produced by incomplete 
combustion of organic material (15-17). PAHs are 
found in tobacco smoke, roasted coffee, in charcoal 
broiled, barbecued or smoked meats, vegetable oils, 
and baker’s yeast (15, 17). They are also found in 
automobile exhaust creosote, coal tar, and petroleum 
asphalt (15, 19, 20). PAHs are found in soil are 
usually adsorbed on soil particulates, and undergo 
degradation by soil microorganisms (15, 18, 21). They 
can persist in the soil from days to years, depending 
on the soil adsorbent and the microorganisms present 
(15, 17). They are expected to be immobile in soil and 
are not readily soluble in water (17).
The toxic effects of PAHs are primarily directed 
toward tissues that contain proliferating cells (22-24). 
For example, animal studies indicate that exposure 
to PAHs can damage cells of the hematopoietic 
and the lymphoid systems, the rapidly dividing cells 
of the intestinal epithelium, spermatogonia, and 
spermatocytes in the testis, and the primary oocytes 
of the ovary (25-29). Most of these effects have been 
observed following both chronic oral and parenteral 
exposures. The primary concern with PAH exposure is 
the potential for carcinogenicity and immunotoxicity 
(30). Although animal studies indicate carcinogenic 
properties, currently there is no direct evidence of their 
carcinogenic potential in humans (31).
Petroleum hydrocarbons describe a mixture 
of organic compounds found in or derived from 
geological substances such as oil, bitumen, and coal. 
Petroleum products released to the environment, such 
as gasoline, crude oil, and jet fuel, typically contain 
hundreds to thousands of compounds in varying 
proportions, composed primarily of carbon and 
hydrogen with minor amounts of nitrogen, sulfur, and 
oxygen (32). The properties of petroleum hydrocarbon 
contamination in soils vary with the petroleum 
source and composition, degree of processing, 
soil type, and weathering. Assessment of human 
health risks associated with petroleum hydrocarbon 
contamination in soil is further complicated by the 
complexity of petroleum products, the variability of 
sources, and site-specific circumstances (32).
Petroleum hydrocarbon constituents of various 
petroleum products include aliphatic compounds 
(straight-chain, branched-chain, and cyclic alkanes 
and alkenes) and aromatic hydrocarbon compounds 
(33, 34). Despite the large number of hydrocarbons 
found in petroleum products and the widespread 
nature of petroleum use and contamination, only a 
relatively small number of the petroleum hydrocarbons 
are well characterized for toxicity (32).
The toxicology of petroleum hydrocarbons 
has been reviewed by the US Total Petroleum 
Hydrocarbons Working Group (US TPHCWG), which 
was formed by the US Department of Defense in 
the mid-1990s (36, 37). The TPHCWG defined 14 
aromatic and aliphatic sub-fractions of petroleum 
hydrocarbons. The Petroleum Hydrocarbon Canada 
Wide Standard (PHC CWS) uses these TPHCWG-
derived sub-fractions for the assessment of human 
health and ecological risk. The PHC CWS places these 
sub-fractions into four practical fractions of straight-
chain petroleum hydrocarbon constituents. These 
include Fraction 1 (hydrocarbon chains equivalent to 
6 to 10 hydrocarbon bonds; nC6 to nC10), Fraction 2 
(nC10 to nC16), Fraction 3 (nC16 to nC34), and Fraction 4 
(greater than nC35) (28, 29). Within these sub-fractions 
the ratio of aromatic and aliphatic constituents is 
assumed to be 20/80 (36, 37).
Exposure to petroleum hydrocarbons leads to a 
variety of health effects, depending on compounds 
or mixtures involved, exposure pathway, intensity, 
frequency, and duration. Only a small number of 
petroleum hydrocarbons are confirmed human 
carcinogens (i.e., benzene, benzo(a)pyrene), and most 
petroleum hydrocarbons are considered as threshold 
toxins that elicit general narcosis symptoms and are 
not considered carcinogenic (32).
Human Health Risk Assessment is a process 
that involves the characterization of the probability 
of adverse human health effects that are associated 
with exposure to environmental chemicals (38, 
39). Human health risk assessment is not an exact 
science. Methodologies utilized in HHRA cannot be 
employed to connect a disease to chemical exposures, 
nor can they be used to prove that exposures to a 
particular chemical agent caused a person’s disease. 
Unlike epidemiological studies where the association 
between past chemical exposures and disease 
in a subpopulation is evaluated, HHRA is utilized 
to estimate whether existing or future chemical 
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exposures will pose health risks to a large population 
of people who may reside in a city or a community. 
The purpose of the HHRA for the proposed park 
development “River Landing” was to quantify the 
degree of potential health risk posed by contamination 
at the subject site. The HHRA was undertaken using 
protocols and methodologies proposed and readily 
accepted by the Canadian Council of Ministers of 
the Environment (CCME), Health Canada, and the 
United States Environmental Protection Agency 
(US EPA) (40-42). These guiding principles of risk 
assessment were utilized to predict the potential for 
human health risk associated with potential exposure 
to environmental chemicals as identified in a Phase 
II Environmental Site Assessment (ESA) for the 
proposed River Landing Development (43). Although 
more traditional remediation options were considered, 
the risk assessment approach was chosen since it 
represented the best available technology.
The risk assessment included the following elements; 
hazard identification, receptor characterization, dose 
response assessment, exposure assessment, and risk 
characterization. This article outlines and describes 
the risk assessment approach applied for the City of 
Saskatoon’s proposed park development.
SITE CHARACTERIZATION
The park development site referred to as “River 
Landing” is located in the city’s core along the west 
bank of the South Saskatchewan River. The park
location is bound by a freeway bridge to the east, a 
residential district to the west, a former coal-powered 
electrical generating plant to the north, and the South 
Saskatchewan River to the south. The development site 
is comprised of a relatively narrow strip of land; sod-
covered and fully landscaped with pedestrian pathways, 
trees, and shrubs. Underground utility lines including 
storm sewers, power, natural gas, and fibre optics were 
present at the site and a pump house, built in the early 
1900’s to supply cooling water to the former power 
plant, was the only building in the development area.
Preliminary studies were conducted at the site 
over a period of two years and included Phase I and II 
Environmental Site Assessments (ESAs), geotechnical 
investigations, and a hazardous materials assessment. 
Information gathered from the initial ESAs revealed 
that inorganic materials (toxic and heavy metals), 
PHCs, and PAHs at concentrations exceeding the 
2006 CCME Parkland/Residential (P/R) assessment 
criteria (44) were randomly distributed in soil fill. The 
soil fill materials, deposited sometime between 1956 
and 1966, reportedly incorporated demolition debris, 
cinders and ash from a variety of sources, including a 
former downtown rail yard and the power plant formerly 
located to the north of the site. Historically, fill materials 
were utilized to increase the elevation of the site from 
the west shore of the South Saskatchewan River that 
confines the south side of the development property.
Four major fill areas (i.e., Area Nos. I through IV, 
inclusive) were identified on the basis of the ESAs. 
Chemical constituents measured in the soil fill 
included toxic and heavy metals (i.e., arsenic, barium, 
copper, lead, mercury, nickel, selenium, and/or zinc) 
and PAHs at concentrations exceeding the 2006 CCME 
P/R criteria; and residual hydrocarbons (i.e., Fraction 
2, Fraction 3, and Fraction 4) at concentrations 
exceeding the 2006 Saskatchewan Environment 
Coarse Grained Residential Soil Criteria (36). Although 
contaminants were identified at grade, those exhibiting 
the highest concentrations were typically located 
at depths ranging from three to approximately five 
metres below grade. Exceptions to this were PHCs 
(i.e., Fraction 2, Fraction 3, and/or Fraction 4), which 
were detected at or near the ground surface.
Even though only four major areas of soil fill were 
identified at the site, the randomness of the fill deposits 
suggested that other areas of impacted fill could exist. 
Further, the lack of information regarding past use of 
the site suggested that the likelihood of identification 
of these fill areas was unlikely without extensive, costly 
investigation. Although remediation of the site could 
have been accomplished by removing the impacted 
materials, it was recognized that accurate costs for 
this option could not be established since the volume 
of impacted soil was unknown. In light of the above, 
a site-specific HHRA was employed to determine 
whether existing chemical constituents at the site 
would adversely affect the health of potential “River 
Landing” park users.
RISK ASSESSMENT
The HHRA included hazard identification, receptor 
characterization, exposure assessment, dose/response 
assessment, and risk characterization. The approach 
taken for each step is described in the subsequent 
sections.
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Hazard Identification
The aim of hazard identification, based on human 
health considerations, was to identify contaminants 
of potential concern (COPC) at the site. COPC were 
selected by review and comparison of concentrations 
of toxic and heavy metals, PAHs, and PHCs measured 
at the site to the CCME (44) P/R guidelines established 
to protect human health. Chemical constituents 
at concentrations exceeding the CCME (44) P/R 
guidelines were selected for assessment, while those 
below the guidelines were discarded. In order to provide 
a substantial safety margin, and an overestimation of 
potential risk, the maximum chemical concentrations 
measured at the site were used to assess the potential 
risks associated with human exposure. Through review 
of animal and human toxicity data the range of toxic 
effects attributed to potential exposure to COPC along 
with the chemical fate and behavior of the COPC in 
the body and the soil were discussed in this step.
Receptor Characterization
The second step was the characterization of 
potential human receptors. In other words, the 
categories of humans who could potentially be 
exposed to COPC at the site were identified in this step. 
Human receptor characteristics such as soil ingestion/
inhalation rates, weight, skin surface area, age, and 
time spent outdoors were obtained from Richardson 
(45), summarized, and then subsequently utilized to 
calculated estimated daily intakes to COPC.
Since the proposed use of the site is a recreational 
park, three categories of human receptors, namely 
children, adults, and construction/utility workers, 
were identified for assessment. Construction workers 
were defined as individuals involved in development 
of the site, while the category of children included 
infants, toddlers, and children as defined by Health 
Canada (46). The age ranges of the infant (0 to 6 
months), toddler (7 months to 4 years), and child (5 
to 12 years) categories were summed so that a full 
exposure duration of 12 years was used to assess 
potential risk. For adults and construction workers, 
standard receptor characteristics (46) were used, 
and these individuals were defined as persons aged 
18 years and older.
Exposure Assessment
The exposure assessment involved a description 
of the likelihood, magnitude, frequency, and duration 
of exposure to COPC as well as the identification of 
possible exposure routes. The most likely exposures 
were: long-term, low-level exposure and direct 
contact (i.e., ingestion, dermal absorption, inhalation 
of suspended particulate matter). The maximum 
contaminant concentrations of COPC identified at the 
site were used to estimate the magnitude of receptor 
exposure, or the exposure dose. The bioavailability of 
COPC, defined (in part) as the fraction of the exposure 
dose that absorbs into the body and reaches the blood 
stream of human receptors, was considered 100 % 
in cases of oral and inhalatory exposure routes. The 
bioavailability factor of dermal absorption was applied 
for consideration of the dermal route of exposure.
Realistic recreational exposure scenarios reflective 
of site-specific human activity patterns at the site were 
applied to provide an overall evaluation of potential risk 
of exposure to COPC at the proposed development. 
It was assumed that an infant would visit the site 12 
hours a week, 32 weeks a year (mid March to mid 
November), a toddler would visit the site 17 hours a 
week, 32 weeks a year for 4.5 years, and a child would 
visit the site 20 hours a week, 32 weeks a year for 7 
years. An exposure duration of 12 years was used to 
assess potential risk to children exposed to COPC at 
the site. For adults, it was assumed they would visit the 
site 19.25 hours a week, 32 weeks a year (mid March 
to mid November; when the ground is not likely to be 
frozen), over a lifetime of 70 years. Construction/utility 
workers were assumed to be at the site an average 
of 5 days a week, (40 hours a week), 28 weeks a year 
for 0.5 years (the duration of time assumed for site 
development) (45, 47, 48).
Dose Response Assessment
The nature of the relationship between the received 
dose (estimated daily intake) and the probability of 
an adverse biological response was evaluated in the 
dose-response step. Estimated daily intakes (EDIs) 
through each route of exposure were calculated 
individually for each COPC. EDIs are an approximation 
of the amount of COPC potentially absorbed into 
the body through each of the dermal (skin), oral 
(gastrointestinal), and respiratory (respiratory system) 
routes of exposure. EDIs were based on maximum 
measured COPC concentrations and calculated using 
standard mathematical formulas commonly used in 
the risk assessment process and established by Health 
Canada (46).
Toxicity benchmarks, defined as the amount of 
contaminant exposure that can occur without adverse 
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health effects, were also identified in this step. Toxicity 
benchmarks are generally determined from exposure 
data obtained from controlled animal and human 
laboratory tests and/or epidemiological studies. The 
toxicity benchmarks used in this study were the most 
restrictive published values available from Health 
Canada and the USEPA. Toxicity benchmarks are 
expressed as either Reference Doses (RfD) and/or 
Slope Factors (SF). RfD (41, 42) are determined 
for threshold toxicants (non-carcinogenic) and SF 
are determined for non-threshold toxicants (health 
effect is considered a cancer or a heritable mutation). 
Toxicity benchmarks were applied with the calculated 
EDI to mathematical models to derive a risk factor 
for each COPC. The calculated risk factor for each 
COPC was ultimately used to characterize potential 
risk associated with exposure to COPC at the site.
Risk Characterization
Risk characterization was the final step in the risk 
assessment process, and involved a determination of 
a numerical estimation of risk, and the integration of 
all information gathered through hazard identification, 
dose response, and exposure assessment to estimate 
human health risk associated with exposure to 
contaminants at the development site. Health risks 
were estimated numerically by comparing EDIs 
to acceptable toxicity benchmarks. Both EDI and 
toxicity benchmarks were applied to mathematical 
models for evaluating risk for both non-threshold (i.e., 
non-carcinogenic) and threshold (i.e., carcinogenic) 
toxicants.
For threshold toxicants, the reference dose-hazard 
quotient methodology was used to quantitatively 
assess the potential hazards presented by exposure. 
In this methodology, following the Health Canada 
(41) and USEPA HHRA Guidelines (42), the human 
risk estimate was expressed as a Hazard Quotient 
(HQ). For threshold toxicants, calculated EDIs were 
expressed as a ratio of acceptable daily intakes or 
reference doses (RfD). The numerical estimation 
of risk for non-carcinogenic contaminants (HQ) is 
defined as follows: HQ = EDIsoil/RFDoral + EDIair/
RFDinhalation + EDIdermal/RFDdermal. In the case where 
RFDdermal and/or RFDinhalational were not available the 
RFDoral value was utilized to calculate HQ. A HQ of 
0.2 for any threshold toxicant COPC was used to 
assess acceptable exposure from each individual 
pathway and was utilized as reference point. Thus 
for threshold-response contaminants, a HQ that was 
less than or equal to 0.2 indicated that the potential 
exposure was within the degree of exposure that was 
considered acceptable or “safe”.
For carcinogenic contaminants, risk was calculated 
by multiplying the estimated intake by the appropriate 
slope factor (SF). The estimate corresponds to an 
incremental risk of an individual developing cancer 
over a lifetime as a result of exposure. The calculated 
risk was then compared to an acceptable benchmark. 
Target levels of acceptable cancer risk (acceptable 
benchmarks) vary depending on regulatory agency, 
but are usually in the range of 1 in 100,000 (i.e., 1 
extra cancer death per 100,000 people exposed to 
a contaminant over their lifetime) to 1 in 1,000,000 
(i.e., 1 extra cancer death per 1 million people exposed 
to a contaminant over their lifetime). A risk level of 
1x10-5, which is the benchmark level recommended 
by Health Canada, was used in the risk assessment for 
comparison to calculated risk values (41, 42). Cancer 
risk levels that were less than 1x10-5 were viewed as 
acceptable.
The HQ’s for all COPC were well below the 
target value for all receptors (i.e., 0.2). The risk level 
calculated for all non-threshold COPC also fell well 
below the target value (1.0x10-5) for carcinogenic 
effects. In other words, the overall assessment strongly 
suggested that there was no significant health risk 
posed by non-carcinogenic and/or carcinogenic 
COPC at the proposed site.
CONCLUSION
The results of the human health risk assessment 
indicated that exposure to the maximum concentrations 
of COPC identified at the site would not result in 
adverse human health effects to park users. Further, 
the magnitude and distribution of COPC at the site 
were such that extensive remediation was not required, 
and no significant restrictions on the proposed use of 
the site were recommended.
Construction at the site commenced in 2007 
following extensive public review, as well as regulatory 
approval and permitting by various agencies, including 
Health Canada and Saskatchewan Environment.
In terms of assessing health risk, utilizing 
environmental data that is perhaps not complete 
and where the extent of contamination may not be 
fully delineated leads to uncertainty in risk assessment. 
There are several categories of uncertainties associated 
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with site-specific risk assessments, and these were 
addressed in the project. Limitations arise primarily 
as a result of uncertainties in each of the steps of the 
risk assessment process. One is the initial selection 
of substances used to characterize exposures and risk 
on the basis of sampling data and available toxicity 
information. Another source of uncertainty is inherent 
in the toxicity values for each substance used to 
characterize risk. Additional uncertainties are inherent 
in exposure assessment for individual substances 
and individual exposures. These uncertainties arise 
from the assumptions utilized to estimate exposure 
concentrations and population intake parameters. 
Finally, uncertainties are incorporated in risk 
assessment when exposures to several substances 
across multiple pathways are summed. To address 
these uncertainties, conservative methods and 
assumptions were prescribed to ensure that exposures 
and risks were not underestimated.
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Sa`etak
PRISTUP PROCJENI ZDRAVSTVENOGA RIZIKA ZA LJUDE PRILIKOM IZGRADNJE GRADSKOGA 
PARKA
Napravljena je procjena zdravstvenoga rizika za ljude (izv. human health risk assessment, HHRA) za projekt 
gradskoga parka “River Landing” koji bi se trebao izgraditi du` sjeverne obale rijeke South Saskatchewan 
u Saskatoonu, saveznoj dr`avi Saskatchewan u Kanadi. Svrha je procjene bila utvrditi mogu li kemijski 
spojevi zate~eni na gradili{tu, uklju~uju}i policikli~ke aromatske ugljikovodike, naftne ugljikovodike te 
toksi~ne i te{ke metale, {tetno utjecati na zdravlje gra|evinskih radnika i korisnika parka. Premda je 
razmotrena i uporaba tradicionalnijih metoda sanacije, izabran je ovaj pristup procjeni rizika zbog toga 
{to rabi najbolju dostupnu tehnologiju. Procjena rizika provedena je prema protokolima i metodama koje 
je odmah usvojio Kanadski savjet ministara za za{titu okoli{a (izv. Canadian Council of Ministers of the 
Environment, CCME), savezni ured za zdravlje Health Canada te Agencija za za{titu okoli{a Sjedinjenih 
Dr`ava (izv. United States Environmental Protection Agency, US EPA). Procjena rizika pokazala je da 
koli~ina i rasprostranjenost kemikalija na gradili{tu nisu takvi da zahtijevaju opse`niju sanaciju, te da se 
lokacija mo`e izgraditi bez zna~ajnih ograni~enja u namjeni. Procjenom je tako|er utvr|eno da eventualno 
izlaganje sastavnicama tla ne}e dovesti do {tetnih posljedica za zdravlje gra|evinskih radnika koji rade na 
parku, a niti za budu}e korisnike parka.
KLJU^NE RIJE^I: ekolo{ka procjena gra|evinske lokacije, kemijski one~i{}iva~i, naftni ugljikovodici, 
odmori{te na rijeci, policikli~ki aromatski ugljikovodici, te{ki metali, tlo, toksi~ni metali
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